Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen R Plymate

Showing results (71-80 of 119) with videos related to

Pageof 12
Sort By:
Journal of Alzheimer'S Disease : JAD|April 24, 2008
Intranasal insulin administration dose-dependently modulates verbal memory and plasma amyloid-beta in memory-impaired older adultsMark A Reger, G Stennis Watson, Pattie S Green, et al.
Molecular Cancer Research : MCR|January 22, 2016
BET Bromodomain Inhibitors Enhance Efficacy and Disrupt Resistance to AR Antagonists in the Treatment of Prostate CancerIrfan A Asangani, Kari Wilder-Romans, Vijaya L Dommeti, et al.
Molecular Cancer Therapeutics|February 15, 2020
Antitumor Activity of the IGF-1/IGF-2-Neutralizing Antibody Xentuzumab (BI 836845) in Combination with Enzalutamide in Prostate Cancer ModelsUlrike Weyer-Czernilofsky, Marco H Hofmann, Katrin Friedbichler, et al.
Molecular Cancer Research : MCR|February 12, 2024
Unraveling the Global Proteome and Phosphoproteome of Prostate Cancer Patient-Derived XenograftsZoi E Sychev, Abderrahman Day, Hannah E Bergom, et al.
Biorxiv : the Preprint Server for Biology|August 14, 2023
Unraveling the Global Proteome and Phosphoproteome of Prostate Cancer Patient-Derived XenograftsZoi E Sychev, Abderrahman Day, Hannah E Bergom, et al.
Plos One|June 2, 2018
A phase I study of niclosamide in combination with enzalutamide in men with castration-resistant prostate cancerMichael T Schweizer, Kathleen Haugk, Jožefa S McKiernan, et al.
The Journal of Clinical Investigation|July 21, 2010
Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variantShihua Sun, Cynthia C T Sprenger, Robert L Vessella, et al.
Plos One|August 16, 2018
Correction: A phase I study of niclosamide in combination with enzalutamide in men with castration-resistant prostate cancerMichael T Schweizer, Kathleen Haugk, Jožefa S McKiernan, et al.
The Prostate|September 8, 2007
Regulation of global gene expression in the bone marrow microenvironment by androgen: androgen ablation increases insulin-like growth factor binding protein-5 expressionChang Xu, Lynn F Graf, Ladan Fazli, et al.
Archives of Neurology|September 14, 2011
Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trialSuzanne Craft, Laura D Baker, Thomas J Montine, et al.
Pageof 12

Showing results (71-80 of 119) with videos related to

Sort By:
Pageof 12
Journal of Alzheimer'S Disease : JAD|April 24, 2008
Intranasal insulin administration dose-dependently modulates verbal memory and plasma amyloid-beta in memory-impaired older adultsMark A Reger, G Stennis Watson, Pattie S Green, et al.
Molecular Cancer Research : MCR|January 22, 2016
BET Bromodomain Inhibitors Enhance Efficacy and Disrupt Resistance to AR Antagonists in the Treatment of Prostate CancerIrfan A Asangani, Kari Wilder-Romans, Vijaya L Dommeti, et al.
Molecular Cancer Therapeutics|February 15, 2020
Antitumor Activity of the IGF-1/IGF-2-Neutralizing Antibody Xentuzumab (BI 836845) in Combination with Enzalutamide in Prostate Cancer ModelsUlrike Weyer-Czernilofsky, Marco H Hofmann, Katrin Friedbichler, et al.
Molecular Cancer Research : MCR|February 12, 2024
Unraveling the Global Proteome and Phosphoproteome of Prostate Cancer Patient-Derived XenograftsZoi E Sychev, Abderrahman Day, Hannah E Bergom, et al.
Biorxiv : the Preprint Server for Biology|August 14, 2023
Unraveling the Global Proteome and Phosphoproteome of Prostate Cancer Patient-Derived XenograftsZoi E Sychev, Abderrahman Day, Hannah E Bergom, et al.
Plos One|June 2, 2018
A phase I study of niclosamide in combination with enzalutamide in men with castration-resistant prostate cancerMichael T Schweizer, Kathleen Haugk, Jožefa S McKiernan, et al.
The Journal of Clinical Investigation|July 21, 2010
Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variantShihua Sun, Cynthia C T Sprenger, Robert L Vessella, et al.
Plos One|August 16, 2018
Correction: A phase I study of niclosamide in combination with enzalutamide in men with castration-resistant prostate cancerMichael T Schweizer, Kathleen Haugk, Jožefa S McKiernan, et al.
The Prostate|September 8, 2007
Regulation of global gene expression in the bone marrow microenvironment by androgen: androgen ablation increases insulin-like growth factor binding protein-5 expressionChang Xu, Lynn F Graf, Ladan Fazli, et al.
Archives of Neurology|September 14, 2011
Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trialSuzanne Craft, Laura D Baker, Thomas J Montine, et al.
Pageof 12